Skip to main content
. 2022 Mar 21;9:842532. doi: 10.3389/fcvm.2022.842532

Figure 2.

Figure 2

Changes in left ventricle ejection fraction (LVEF) during the treatment. Compared to baseline, LVEF did not change during the chemotherapy with doxorubicin (p = 0.178).